550
Views
18
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Low Dose Intravenous Ascorbic Acid for Erythropoietin-Hyporesponsive Anemia in Diabetic Hemodialysis Patients with Iron Overload

, M.D., , &
Pages 445-453 | Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

George Kosmadakis, Enrique Da Costa Correia, Odette Carceles, Frederic Somda & Didier Aguilera. (2014) Vitamins in dialysis: who, when and how much?. Renal Failure 36:4, pages 638-650.
Read now

Articles from other publishers (16)

Bereket Tessema Lodebo, Anuja Shah & Joel D. Kopple. (2018) Is it Important to Prevent and Treat Protein-Energy Wasting in Chronic Kidney Disease and Chronic Dialysis Patients?. Journal of Renal Nutrition 28:6, pages 369-379.
Crossref
Tanjim Sultana, Maria V. DeVita & Michael F. Michelis. (2016) Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency. International Urology and Nephrology 48:9, pages 1519-1524.
Crossref
Fredric O. Finkelstein, Peter Juergensen, Suxin Wang, Sally Santacroce, Mark Levine, Peter Kotanko, Nathan W. Levin & Garry J. Handelman. (2011) Hemoglobin and Plasma Vitamin C Levels in Patients on Peritoneal Dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 31:1, pages 74-79.
Crossref
Marie Philipneri. (2009) Lowering the Erythropoietin Requirement for Dialysis Patients with Functional Iron Deficiency Using Ascorbic Acid (Vitamin C). Dialysis & Transplantation 38:8, pages 314-319.
Crossref
Nosratola D Vaziri. (2008) Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?. Nature Clinical Practice Nephrology 4:8, pages 436-445.
Crossref
Sarah Tomasello. (2008) Anemia of Chronic Kidney Disease. Journal of Pharmacy Practice 21:3, pages 181-195.
Crossref
Der-Cherng Tarng. (2007) Novel Aspects of Vitamin C in Epoetin Response. Journal of the Chinese Medical Association 70:9, pages 357-360.
Crossref
Petra Seeber & Aryeh Shander. 2007. Basics of Blood Management. Basics of Blood Management 35 49 .
Walter H. Hörl. (2007) Iron therapy for renal anemia: how much needed, how much harmful?. Pediatric Nephrology 22:4, pages 480-489.
Crossref
Der-Cherng Tarng. (2006) How Can Erythropoietin Requirements be Reduced in Dialysis Patients?. Seminars in Dialysis 19:5, pages 367-369.
Crossref
. (2006) References. American Journal of Kidney Diseases 47, pages S132-S145.
Crossref
Steven Fishbane. (2006) EPO Adjuvant Treatments: A Need for More Evidence. American Journal of Kidney Diseases 47:4, pages 683-685.
Crossref
Nizar Attallah, Yahya Osman-Malik, Stan Frinak & Anatole Besarab. (2006) Effect of Intravenous Ascorbic Acid in Hemodialysis Patients With EPO-Hyporesponsive Anemia and Hyperferritinemia. American Journal of Kidney Diseases 47:4, pages 644-654.
Crossref
DORIS CHAN, ASHLEY IRISH & GURSHARAN DOGRA. (2005) Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. Nephrology 10:4, pages 336-340.
Crossref
Jeffrey S. Berns & Ari Mosenkis. (2005) Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Hemodialysis International 9:1, pages 7-22.
Crossref
. (2003) Current literature in diabetes. Diabetes/Metabolism Research and Reviews 19:6, pages 494-501.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.